Company Information

  

Address: 5885 HOLLIS STREET, SUITE 100  
City: EMERYVILLE 
State: CA 
Zip Code: 94608 
Telephone: 510-450-0761 

Description of Business

Primary SIC Code: 2860
(As filed with the SEC)  

Amyris, Inc. (or the "Company," "Amyris," "we," "us," or "our") is a leading integrated industrial biotechnology company that is applying its technology platform to engineer, manufacture and sell high performance, low cost products into the Health and Nutrition, Personal Care and Performance Materials markets. Our proven technology platform allows us to rapidly engineer microbes and use them as catalysts to metabolize renewable, plant-sourced sugars into large volume, high-value ingredients. Our biotechnology platform and industrial fermentation process replaces existing complex and expensive chemical manufacturing processes. We believe industrial synthetic biology represents a third industrial revolution, bringing together biology and engineering to generate new, more sustainable materials to meet the growing global demand for bio-based replacements for petroleum, animal- or plant-derived ingredients.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
06/2017-5.38NAN/E
03/2017-101.24NAN/E

Key Financial Ratios and Statistics

FYE: 12/31

Profitability 2016 Leverage 2016
Net Inc/Comm Equity-0.10Total Liab/Total Assets2.38
Net Inc/Total Assets-0.78Total Liab/Inv Cap-7.72
Net Inc/Inv Cap2.53Total Liab/Comm Equity0.31
Pretax Inc/Net Sales-1.44Interest Coverage Ratio-1.57
Net Inc/Net Sales-1.51Curr Debt/Equity-0.33
Cash Flow/Net Sales-1.23LTD/Equity-0.95
SG&A/NetSales0.71Total Debt/Equity-1.28
Asset Utilization   Liquidity  
Net Receivables Turnover7.01Quick Ratio0.48
Inventory Turnover7.48Current Ratio0.54
Inventory Day Sales0.03Net Rec/Curr Assets0.24
Net Sales/Work Cap-1.32Inv/Curr Assets0.11
Net Sales/PP&E1.25  

Income Statement (Millions)

  6/30/2017 3/31/2017 12/31/2016 9/30/2016
Total Revenues(Net Sales) 25.68 12.98 22.24 26.55
Cost of Goods Sold 17.28 12.77 30.04 14.88
Selling & Admin Exps 16.02 12.78 12.67 11.38
Operating Income -21.80 -27.34 -34.48 -12.03
Interest Exp 9.30 12.18 11.64 7.93
Pretax Income 0.93 -37.41 -48.60 -19.56
Other Income 32.03 2.12 -2.48 0.40
Net Income Bef Extraordinary ... NA NA NA NA
Net Income 0.52 -37.28 -52.04 -20.57

Balance Sheet (Millions)

Assets 6/30/2017 3/31/2017 12/31/2016 9/30/2016
Cash & Short Term Investments 10.45 2.79 32.85 2.57
Receivables - Total 17.39 8.54 13.98 6.36
Inventories - Total 5.73 7.08 6.21 7.90
Total Current Assets 41.01 24.05 59.12 21.12
Net Property, Plant & Equipment 49.30 53.05 53.74 63.09
Total Assets 112.71 95.44 129.87 99.42
Liabilities        
Accounts Payable 43.93 48.26 44.50 48.67
Debt in Current Liabilities 13.88 49.86 60.08 75.96
Total Current Liabilities 62.82 101.61 109.87 131.73
Long-Term Debt 210.67 177.03 175.12 107.38
Total Liabilities 295.16 302.63 309.32 256.80
Stockholder's Equity        
Minority Interest 0.94 0.94 0.94 -0.11
Preferred Stock 0.00 0.00 0.00 0.00
Common Stock 0.00 0.03 0.03 0.03
Retained Earnings -1,171.19 -1,171.81 -1,134.44 -1,085.68
Treasury Stock NA NA NA NA
Total Stockholders' Equity -200.28 -212.19 -184.45 -162.38
Total Liabilities and Stockholders' Equity 94.88 90.44 124.87 94.42

Cash Flow Summary (Millions)

Categories 6/30/2017 3/31/2017 12/31/2016 9/30/2016
Net Cash Provided by Operating Activities -34.79 -25.39 -36.98 -6.41
Net Cash Provided by Investing Activities -5.21 3.90 6.14 -0.32
Net Cash Provided by Financing Activities 43.18 -3.76 57.42 6.98

Annual Summary Data (Millions)

Year Sales Net Income EPS
12/201273.69-206.06--
12/201341.12-255.02--
12/201443.27-8.23--
12/201534.15-219.09--
12/201667.19-101.48--
Growth Rates-2.28----

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional09/30/17527,43919.78




Report Date : 10/9/2017

Powered By Edgar Online © 2017EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.